Quality-adjusted time without symptoms or toxicity (Q-TWiST): Analysis of cabozantinib (Cabo) vs sunitinib (Sun) in patients with advanced renal cell carcinoma (aRCC) of intermediate or poor risk (Alliance A031203) Meeting Abstract
| Authors: | Chen, R. C.; Feuilly, M.; Meng, J.; Lister, J.; Marteau, F.; Morris, M. J.; George, D. J.; Choueiri, T. K. |
| Abstract Title: | Quality-adjusted time without symptoms or toxicity (Q-TWiST): Analysis of cabozantinib (Cabo) vs sunitinib (Sun) in patients with advanced renal cell carcinoma (aRCC) of intermediate or poor risk (Alliance A031203) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 255s |
| Language: | English |
| ACCESSION: | WOS:000442916002083 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.4556 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4556 -- Source: Wos |
